# 3D endothelial network formation in hydrogels improved by stromal cells and specific growth factors

**Authors:** Ivana Acimovic, Vaclav Chochola, Jose Luis Herrera, Ales Hampl, Josef Jaros

PMC · DOI: 10.1038/s41598-025-25381-x · Scientific Reports · 2025-11-24

## TL;DR

Researchers improved 3D blood vessel formation in lab-grown tissues using stromal cells and specific growth factors in special gels.

## Contribution

A new method for forming vascular networks using stromal cell stimulation instead of VEGF in xeno-free conditions.

## Key findings

- Vascular networks can form in hydrogels without VEGF when stromal cells are stimulated with IGF1, FGF2, and EGF.
- Xeno-free and chemically defined conditions support successful vascular network formation in co-cultures.
- Human dental pulp and adipose stromal cells both support endothelial network formation in 3D hydrogels.

## Abstract

The limiting factor in the current state-of-the-art bioengineering of human tissues/organoids in vitro is the lack of functional vasculature that would support growth, metabolic waste removal, and oxygen supply of the formed constructs. The three-dimensional (3D) tissues can be formed by utilization of specific cell types, different hydrogels and scaffolds that provide a physical support, in addition to specific medium composition. Establishment of chemically defined xeno-free conditions is of great interest when keeping in mind the transition from basic research to therapeutic applications. In this study, we present the formation of vascular network of human umbilical vein endothelial cells co-cultured with stromal cells (SCs), human dental pulp SCs or human adipose SCs, in natural hydrogels (Matrigel, GelMA) as well as xeno-free VitroGel hydrogels. As medium composition plays a pivotal role in the successful generation of biological constructs in vitro, we evaluated the potency of specific growth factors (GFs) to induce vascular network formation in 3D hydrogels. We confirmed that vascular endothelial growth factor (VEGF), the most used pro-angiogenic factor, is not mandatory in culture medium for vascular network formation. Rather the endothelial cell (EC) network in co-culture of ECs and SCs can be formed through stimulation of SCs with GFs such as insulin-like growth factor 1 (IGF1), basic fibroblast growth factor (FGF2), and epidermal growth factor (EGF) regardless of serum presence in the medium. Also, we tested completely chemically defined medium that, when used together with xeno-free hydrogel, presents a step forward to application of such tissue constructs in translational regenerative medicine.

The online version contains supplementary material available at 10.1038/s41598-025-25381-x.

## Linked entities

- **Proteins:** VEGFA (vascular endothelial growth factor A), IGF1 (insulin like growth factor 1), FGF2 (fibroblast growth factor 2), EGF (epidermal growth factor)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288] {aka KIA, MIB-, MIB-1, PPP1R105}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 281572] {aka VEGF, VEGF-A, VPF, eVEGF120, eVEGF164}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, Kitlg (KIT ligand) [NCBI Gene 60427] {aka Kitl, Mgf, SCF}, AAK1 (AP2 associated kinase 1) [NCBI Gene 532546], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, ALB (albumin) [NCBI Gene 280717], Il3 (interleukin 3) [NCBI Gene 24495], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 54250] {aka Fgf-2, Fgf2a, bFGF}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}
- **Diseases:** sarcoma (MESH:D012509), EHS (MESH:D012513)
- **Chemicals:** phalloidin (MESH:D010590), Alexa Fluor 568 (-), Poly(ethylene oxide) (MESH:D011092), P (MESH:D010758), silicone (MESH:D012828), AA (MESH:D001205), S. (MESH:D013455), Hep (MESH:D006493), phenol red (MESH:D010637), RGD (MESH:C047981), rhodamine phalloidin (MESH:C504731), YIGSR (MESH:C081571), Agarose (MESH:D012685), HC (MESH:D006854), 4',6-diamidino-2-phenylindole (MESH:C007293), PBS (MESH:D007854), CO2 (MESH:D002245), PFA (MESH:C003043), DS (MESH:D003903), Triton X-100 (MESH:D017830), TWEEN 20 (MESH:D011136), rhodamine (MESH:D012235), Fluorescein (MESH:D019793), F-12 (MESH:C007782), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C2519A
- **Cell lines:** HUVEC — Homo sapiens (Human), Finite cell line (CVCL_3722)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12644823/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12644823/full.md

---
Source: https://tomesphere.com/paper/PMC12644823